Phenprocoumon
From Wikipedia, the free encyclopedia
Phenprocoumon
|
|
Systematic (IUPAC) name | |
2-hydroxy-3-(1-phenylpropyl)chromen-4-one | |
Identifiers | |
CAS number | 435-97-2 |
ATC code | B01AA04 |
PubChem | 9908 |
DrugBank | APRD00228 |
Chemical data | |
Formula | C18H16O3 |
Mol. weight | 280.318 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Protein binding | 99% |
Metabolism | hepatic to inactive metabolites |
Half life | 5 to 6 days |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Phenprocoumon is a anticoagulant, functioning as a Vitamin K antagonist. It is a derivative of coumarin and is also marketed under the brand name Marcoumar. It is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders.